Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Active Targeted Nanoparticles for Delivery of Poly(ADP-ribose) Polymerase (PARP) Inhibitors: A Preliminary Review
Saman Sargazi, Mahwash Mukhtar, Abbas Rahdar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10319-10319
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Nanotechnology: A Promising Approach for Cancer Diagnosis, Therapeutics and Theragnosis
Mesfin Dessale, Getachew Mengistu, Hylemariam Mihiretie Mengist
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 3735-3749
Open Access | Times Cited: 97
Surface Engineering of Nanomaterials with Polymers, Biomolecules, and Small Ligands for Nanomedicine
Ana M. Díez‐Pascual
Materials (2022) Vol. 15, Iss. 9, pp. 3251-3251
Open Access | Times Cited: 60
State of the Art in the Antibacterial and Antiviral Applications of Carbon-Based Polymeric Nanocomposites
Ana M. Díez‐Pascual
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10511-10511
Open Access | Times Cited: 59
Application of titanium dioxide nanoparticles in photothermal and photodynamic therapy of cancer: An updated and comprehensive review
Saman Sargazi, Simge Er Zeybekler, Sultan Sacide Gelen, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 75, pp. 103605-103605
Closed Access | Times Cited: 56
Functional Nanomaterials in Biomedicine: Current Uses and Potential Applications
Ana M. Díez‐Pascual, Abbas Rahdar
ChemMedChem (2022) Vol. 17, Iss. 16
Open Access | Times Cited: 53
Polymeric Micelles: Revolutionizing Cancer Therapeutics for Enhanced Efficacy
Imran Ahmad, Poonam Kushwaha, Shazia Usmani, et al.
BioNanoScience (2025) Vol. 15, Iss. 1
Closed Access
Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches
Fatemeh Davodabadi, Mohammad Sarhadi, Javad Arabpour, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 844-875
Open Access | Times Cited: 31
Ligand-based active targeting strategies for cancer theranostics
Anupriya Bandyopadhyay, Tuyelee Das, Samapika Nandy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 12, pp. 3417-3441
Closed Access | Times Cited: 20
Therapeutic Role of Quercetin in Prostate Cancer: A Study of Network Pharmacology, Molecular Docking, and Dynamics Simulation
Fernando Martínez‐Esquivias, Juan Manuel Guzmán‐Flores, Edar O. Pech-Santiago, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access
Novel Perspectives towards RNA-Based Nano-Theranostic Approaches for Cancer Management
Rabia Arshad, Iqra Fatima, Saman Sargazi, et al.
Nanomaterials (2021) Vol. 11, Iss. 12, pp. 3330-3330
Open Access | Times Cited: 38
Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients
Behnam Hashemi, Akram Firouzi‐Amandi, Halimeh Amirazad, et al.
Journal of Drug Delivery Science and Technology (2021) Vol. 67, pp. 102967-102967
Open Access | Times Cited: 27
Role of PARP Inhibitors in Glioblastoma and Perceiving Challenges as Well as Strategies for Successful Clinical Development
Priya Bisht, Vikash Kumar, Ruchi Pandey, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
A carrier-free supramolecular nano-twin-drug for overcoming irinotecan-resistance and enhancing efficacy against colorectal cancer
Miaomiao Yuan, Tong Chen, Lü Jin, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Composition, preparation methods, and applications of nanoniosomes as codelivery systems: a review of emerging therapies with emphasis on cancer
Maryam Roostaee, Atefeh Derakhshani, Hadiseh Mirhosseini, et al.
Nanoscale (2023) Vol. 16, Iss. 6, pp. 2713-2746
Closed Access | Times Cited: 10
Update on Combination Strategies of PARP Inhibitors
Zhuoqun Lin, Lingfang Wang, Ziyu Xing, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 2
Improving the physicochemical and pharmacokinetic properties of olaparib through cocrystallization strategy
Xia-Lin Dai, Bowen Pang, Wenting Lv, et al.
International Journal of Pharmaceutics (2023) Vol. 647, pp. 123497-123497
Closed Access | Times Cited: 7
Effects of folate-conjugated Fe2O3@Au core–shell nanoparticles on oxidative stress markers, DNA damage, and histopathological characteristics: evidence from in vitro and in vivo studies
Habib Ghaznavi, Mohammad Reza Hajinezhad, Milad Shirvaliloo, et al.
Medical Oncology (2022) Vol. 39, Iss. 9
Closed Access | Times Cited: 9
The Current State of the Art in PARP Inhibitor-Based Delivery Nanosystems
Lisha Cai, Xiaoling Xu, Wei Chen
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1647-1647
Open Access | Times Cited: 9
Co-Packaged PARP inhibitor and photosensitizer for targeted photo-chemotherapy of 3D ovarian cancer spheroids
Aaron J. Sorrin, Anika Dasgupta, Kathryn A. McNaughton, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Isoxazole compounds: unveiling the synthetic strategy, In-silico SAR & Toxicity studies and future perspective as PARP inhibitor in cancer therapy
Udita Malik, Dilipkumar Pal
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116898-116898
Closed Access | Times Cited: 1
PARP7i Clinical Candidate RBN‐2397 Exerts Antiviral Activity by Modulating Interferon‐β Associated Innate Immune Response in Macrophages
Xiaoli Du, Jiawei Zhou, Yi Zhou, et al.
Drug Development Research (2024) Vol. 85, Iss. 7
Closed Access | Times Cited: 1
Combating tumor PARP inhibitor resistance: Combination treatments, nanotechnology, and other potential strategies
Rong Wang, Yunxi Liu, Mingqi Liu, et al.
International Journal of Pharmaceutics (2024) Vol. 669, pp. 125028-125028
Closed Access | Times Cited: 1
Live imaging of apoptotic signaling flow using tunable combinatorial FRET-based bioprobes for cell population analysis of caspase cascades
Miho Suzuki, Yutaka Shindo, Ryu Yamanaka, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers
Alessandro Parisi, Francesca Rossi, Chiara De Filippis, et al.
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 585-613
Open Access | Times Cited: 3
A Carrier-Free Supramolecular Nano-Twin-Drug for Overcoming Irinotecan- Resistance and Enhancing Efficacy against Colorectal Cancer
Miaomiao Yuan, Tong Chen, Lü Jin, et al.
Research Square (Research Square) (2023)
Open Access
Page 1 - Next Page

Scroll to top